- December 23, 2021
- Posted by: Stratford Team
- Category: Business
– Business combination results in over $160 million in gross cash proceeds to Hyperfine
– Funds to catalyze commercial expansion of the world’s first FDA-cleared portable MRI system™ and additional organic growth initiatives
– Hyperfine to begin trading on Nasdaq under ticker “HYPR”
GUILFORD, Conn., Dec. 22, 2021 /PRNewswire/ — Hyperfine Inc., the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared portable MRI system™, today announced that it has completed its business combination with HealthCor Catalio Acquisition Corp. (Nasdaq: HCAQ) (“HealthCor”), a special purpose acquisition company sponsored by leading healthcare funds HealthCor Management, L.P. and Catalio Capital Management, LP, and Liminal Sciences, Inc. (“Liminal”), a medical device development company dedicated to non-invasive measurement of key vital signs in the brain. Hyperfine will receive approximately $160 million in gross cash proceeds from the…